Transformation of a low-grade follicular lymphoma into a composite lymphoma combining a high-grade B-cell lymphoma and a lymphoblastic neoplasm expressing Terminal deoxynucleotidyl Transferase: a case report.
Follicular lymphoma
High-grade B-cell lymphoma
Lymphoblastic neoplasm
TdT
Journal
Journal of medical case reports
ISSN: 1752-1947
Titre abrégé: J Med Case Rep
Pays: England
ID NLM: 101293382
Informations de publication
Date de publication:
27 Jul 2020
27 Jul 2020
Historique:
received:
11
11
2019
accepted:
04
06
2020
entrez:
28
7
2020
pubmed:
28
7
2020
medline:
15
5
2021
Statut:
epublish
Résumé
High-grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6 is an aggressive mature B-cell neoplasm, whereas B-lymphoblastic lymphoma is immature cell proliferation, with a frequent positivity for terminal deoxynucleotidyl transferase. The transformation of a low-grade follicular lymphoma into a lymphoblastic neoplasm expressing terminal deoxynucleotidyl transferase is a very rare event. A 55-year-old Caucasian man was followed for a grade 1-2 follicular lymphoma carrying a t(14;18) IGH/BCL2+ and was initially treated with R-CHOP. The follicular lymphoma presented two relapses. In the third relapse, the patient had multiple lymphadenopathy and ascites, which motivated a retroperitoneal biopsy and an ascitic tap. These samples were analyzed by histological, cytological, flow cytometric, cytogenetic, and molecular assessments. The patient died of a multiple organ dysfunction syndrome 2 weeks after his third relapse. The biopsy revealed a diffuse proliferation made up of two types of tumor cells: centroblasts (Bcl-6-positive) and immature cells (terminal deoxynucleotidyl transferase-positive). Flow cytometric analysis confirmed the immature phenotype, with an expression of terminal deoxynucleotidyl transferase, combined with a loss of membrane immunoglobulins. The cytogenetic analysis performed on the ascites revealed a clonal evolution characterized by a t(8;22)(q24;q11) MYC+ translocation not previously detected in follicular lymphoma. Fluorescence in situ hybridization confirmed the double rearrangement of the BCL2 and MYC genes. Polymerase chain reactions and sequencing were used to study the clonal relationship between follicular lymphoma and the secondary tumors. The IGVH gene rearrangement revealed a unique clonal rearrangement involving an IGVH4-59 subset in all three specimens. These findings suggest a clonal relationship between the two types of lymphoma cells. Furthermore, they support the transformation of an acute follicular lymphoma into a composite lymphoma combining a high-grade B-cell lymphoma and a lymphoblastic neoplasm expressing terminal deoxynucleotidyl transferase. This case report highlights the possible transformation of follicular lymphoma into a highly aggressive and immature proliferation.
Sections du résumé
BACKGROUND
BACKGROUND
High-grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6 is an aggressive mature B-cell neoplasm, whereas B-lymphoblastic lymphoma is immature cell proliferation, with a frequent positivity for terminal deoxynucleotidyl transferase. The transformation of a low-grade follicular lymphoma into a lymphoblastic neoplasm expressing terminal deoxynucleotidyl transferase is a very rare event.
CASE PRESENTATION
METHODS
A 55-year-old Caucasian man was followed for a grade 1-2 follicular lymphoma carrying a t(14;18) IGH/BCL2+ and was initially treated with R-CHOP. The follicular lymphoma presented two relapses. In the third relapse, the patient had multiple lymphadenopathy and ascites, which motivated a retroperitoneal biopsy and an ascitic tap. These samples were analyzed by histological, cytological, flow cytometric, cytogenetic, and molecular assessments. The patient died of a multiple organ dysfunction syndrome 2 weeks after his third relapse. The biopsy revealed a diffuse proliferation made up of two types of tumor cells: centroblasts (Bcl-6-positive) and immature cells (terminal deoxynucleotidyl transferase-positive). Flow cytometric analysis confirmed the immature phenotype, with an expression of terminal deoxynucleotidyl transferase, combined with a loss of membrane immunoglobulins. The cytogenetic analysis performed on the ascites revealed a clonal evolution characterized by a t(8;22)(q24;q11) MYC+ translocation not previously detected in follicular lymphoma. Fluorescence in situ hybridization confirmed the double rearrangement of the BCL2 and MYC genes. Polymerase chain reactions and sequencing were used to study the clonal relationship between follicular lymphoma and the secondary tumors. The IGVH gene rearrangement revealed a unique clonal rearrangement involving an IGVH4-59 subset in all three specimens.
CONCLUSION
CONCLUSIONS
These findings suggest a clonal relationship between the two types of lymphoma cells. Furthermore, they support the transformation of an acute follicular lymphoma into a composite lymphoma combining a high-grade B-cell lymphoma and a lymphoblastic neoplasm expressing terminal deoxynucleotidyl transferase. This case report highlights the possible transformation of follicular lymphoma into a highly aggressive and immature proliferation.
Identifiants
pubmed: 32713346
doi: 10.1186/s13256-020-02433-6
pii: 10.1186/s13256-020-02433-6
pmc: PMC7384216
doi:
Substances chimiques
DNA Nucleotidylexotransferase
EC 2.7.7.31
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
117Références
Case Rep Hematol. 2017;2017:6891957
pubmed: 28884033
Leuk Lymphoma. 2016 Nov;57(11):2626-35
pubmed: 26892631
Am J Clin Pathol. 2015 Sep;144(3):393-410
pubmed: 26276770
Leukemia. 2003 Dec;17(12):2257-317
pubmed: 14671650
Am J Dermatopathol. 2014 Apr;36(4):303-10
pubmed: 23907319
Genes Chromosomes Cancer. 1990 Jul;2(2):147-58
pubmed: 2278969
N Engl J Med. 1988 May 26;318(21):1373-8
pubmed: 3285208
Am J Pathol. 2016 Dec;186(12):3273-3284
pubmed: 27750045
Am J Clin Pathol. 2008 Jan;129(1):157-66
pubmed: 18089500
Leuk Lymphoma. 2011 Nov;52(11):2195-9
pubmed: 21718139
Am J Surg Pathol. 2018 Feb;42(2):269-276
pubmed: 29112016
Am J Pathol. 1999 Jun;154(6):1857-66
pubmed: 10362812
Br J Haematol. 2011 Oct;155(2):274-7
pubmed: 21488860
Am J Clin Pathol. 2004 Apr;121(4):512-25
pubmed: 15080303
CA Cancer J Clin. 2016 Nov 12;66(6):443-459
pubmed: 27618563
Am J Surg Pathol. 2010 Mar;34(3):327-40
pubmed: 20118770
Hum Pathol. 2015 Feb;46(2):260-71
pubmed: 25529125
Int J Clin Exp Pathol. 2015 Aug 01;8(8):9602-8
pubmed: 26464726